The Effect of Biliopancreatic Diversion Surgery on Renal Function—a Retrospective Study



The prevalences of obesity and chronic kidney disease (CKD) have increased simultaneously. Should a pathophysiological relationship exist between the two conditions, bariatric surgery and associated weight loss could be an important intervention in extremely obese individuals to slow the progression of CKD.


We conducted a retrospective analysis of 25 patients who had undergone biliopancreatic diversion (BPD) surgery for extreme obesity (body mass index >40 kg/m2), with mean follow-up of 4 years. We assessed pre- and post-surgery renal function, body weight and blood pressure (BP) obtained from electronic hospital and primary care records.


There was a significant reduction in mean body weight at 4 years by 50.3 kg (SD = 20.65). The creatinine and estimated glomerular filtration rate (eGFR) also improved significantly: serum creatinine reduced by 16.2 μmol/l (SD = 19.57) while the eGFR improved by 10.6 ml/min/m2 (SD = 15.45). The greatest improvement in eGFR was in the group (n = 7) with eGFR ≤60 ml/min/m2. A subset of patients (n = 11) had evaluable BP readings and had a reduction in BP of 17/10 mmHg (SD = 33/12).


This retrospective study demonstrates a clinically significant improvement in renal function following BPD. Several mechanisms including weight loss could account for the positive impact on renal function. The physiology underlying this improvement requires further study.

This is a preview of subscription content, access via your institution.

Fig. 1


  1. 1.

    Baskin ML, Ard J, Franklin F, et al. Prevalence of obesity in the United States. Obes Rev. 2005;6(1):5–7.

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235–41.

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–47.

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Snyder JJ, Foley RN, Collins AJ. Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999–2004. Am J Kidney Dis. 2009;53:218–28.

    PubMed  Article  Google Scholar 

  5. 5.

    Ting SMS, Nair H, Ching I, et al. Overweight, obesity and chronic kidney disease. Nephron Clin Pract. 2009;112:c121–7.

    PubMed  Article  Google Scholar 

  6. 6.

    Fox CS, Larson MG, Leip EP, et al. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844–50.

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Kramer H, Luke A, Bidani A, et al. Obesity and prevalent and incident CKD: the hypertension detection and follow-up program. Am J Kidney Dis. 2005;46:587–94.

    PubMed  Article  Google Scholar 

  8. 8.

    Gelber RP, Kurth T, Kausz AT, et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis. 2005;46:871–80.

    PubMed  Article  Google Scholar 

  9. 9.

    Neter JE, Stam BE, Kok FJ, et al. Influence of weight reduction on blood pressure. A meta-analysis of randomized controlled trials. J Hypertens. 2003;42:878–84.

    Article  CAS  Google Scholar 

  10. 10.

    Weisinger JR, Kempson R, Eldidge L, et al. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med. 1974;81:440–7.

    PubMed  CAS  Google Scholar 

  11. 11.

    Chagnac A, Weinstein T, Korzets A, et al. Glomerular haemodynamics in severe obesity. Am J Physiol Ren Physiol. 2000;278:817–22.

    Google Scholar 

  12. 12.

    Kasiske BL, et al. Glomerulosclerosis in patients with massive obesity. Am J Nephrol. 1985;5:45–50.

    PubMed  Article  CAS  Google Scholar 

  13. 13.

    Jennette JC, Charles L, Grubb W. Glomerulomegaly and focal segmental glomerulosclerosis associated with obesity and sleep apnoea syndrome. Am J Kidney Dis. 1987;10:470–2.

    PubMed  CAS  Google Scholar 

  14. 14.

    Praga M, Hernandez E, Andres A, et al. Effects of body weight loss and captopril treatment on proteinuria associated with obesity. Nephron. 1995;70:35–41.

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Navaneethan SD, Yehnert H, Moustarah F, et al. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4(10):1565–74. Epub 2009 Sep 17.

    PubMed  Article  Google Scholar 

  16. 16.

    Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547–59.

    PubMed  Google Scholar 

  17. 17.

    Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.

    PubMed  CAS  Google Scholar 

  18. 18.

    Schuster DP, Teodorescu M, Mikami D, et al. Effect of bariatric surgery on normal and abnormal renal function. Surg Obes Relat Dis. 2011;7(4):459–64.

    PubMed  Article  CAS  Google Scholar 

Download references


Dr. Shahrad Taheri is funded by the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country (CLAHRC BBC) programme. The views expressed in this publication are not necessarily those of the NIHR, the Department of Health, NHS South Birmingham, University of Birmingham or the CLAHRC BBC Theme 8 Management/Steering Group.

Conflict of Interest


Author information



Corresponding authors

Correspondence to Indranil Dasgupta or Shahrad Taheri.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Jose, B., Ford, S., Super, P. et al. The Effect of Biliopancreatic Diversion Surgery on Renal Function—a Retrospective Study. OBES SURG 23, 634–637 (2013).

Download citation


  • Obesity
  • Renal function
  • Weight loss
  • Bariatric surgery